Insider Buying: Stereotaxis, Inc. (NYSEAMERICAN:STXS) Director Buys $11,827.20 in Stock

Stereotaxis, Inc. (NYSEAMERICAN:STXS) Director Paul J. Isaac acquired 7,168 shares of the company’s stock in a transaction that occurred on Thursday, September 14th. The shares were acquired at an average cost of $1.65 per share, for a total transaction of $11,827.20. Following the purchase, the director now directly owns 2,636,807 shares of the company’s stock, valued at $4,350,731.55. The purchase was disclosed in a legal filing with the SEC, which is available at this link.

Stereotaxis Stock Performance

Shares of STXS stock traded down $0.01 during trading hours on Monday, hitting $1.61. 118,768 shares of the company’s stock traded hands, compared to its average volume of 224,830. Stereotaxis, Inc. has a 12-month low of $1.33 and a 12-month high of $2.75. The firm has a market capitalization of $130.20 million, a price-to-earnings ratio of -6.00 and a beta of 1.43.

Stereotaxis (NYSEAMERICAN:STXS) last announced its quarterly earnings data on Thursday, August 10th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.01). Stereotaxis had a negative net margin of 65.98% and a negative return on equity of 78.13%. The company had revenue of $7.86 million for the quarter, compared to analysts’ expectations of $7.20 million. As a group, sell-side analysts forecast that Stereotaxis, Inc. will post -0.25 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Stereotaxis

Several large investors have recently modified their holdings of the stock. Jane Street Group LLC bought a new stake in Stereotaxis during the 4th quarter valued at about $26,000. Raymond James Financial Services Advisors Inc. purchased a new stake in shares of Stereotaxis during the second quarter valued at approximately $27,000. Marshall Wace LLP bought a new stake in shares of Stereotaxis during the fourth quarter valued at approximately $36,000. Squarepoint Ops LLC purchased a new position in Stereotaxis in the 1st quarter worth approximately $44,000. Finally, Lido Advisors LLC bought a new position in Stereotaxis in the 1st quarter valued at approximately $51,000. Hedge funds and other institutional investors own 50.75% of the company’s stock.

About Stereotaxis

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.